Johnson Matthey has announced the appointment of Nicholas Shackley to the role of Global Vice President Innovator Products and Solutions.
In this role Nicholas will lead Johnson Matthey’s (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies and innovative medication.
This offering includes a broad range of enabling technologies and extensive global facilities including R&D centres located in Devens, Massachusetts and Cambridge, UK as well as manufacturing sites in West Deptford, New Jersey; Conshohocken, Philadelphia; North Andover, Massachusetts; and Annan, Scotland. In addition to the existing offer, Nicholas will be responsible for growing the capabilities through addition of new technologies and assets to service the expanding market for technology-enabled custom development and manufacturing solutions.
Nicholas brings a wealth of experience to JM, having most recently held the positon of Senior Vice President at Aceto Corporation where he was responsible for the pharmaceutical ingredients businesses. Prior to this he has had senior positions at BASF, Cambrex and Avecia and holds a BEng from Imperial College, London.
“We are excited to have Nicholas join our Health sector in this critical position,” commented Robert MacLeod, Chief Executive of JM. “His extensive knowledge of the pharmaceutical innovator market coupled with his senior leadership skills will be invaluable in driving our strategic growth-providing solutions to the clinical development and commercial manufacturing needs of the pharma and biotech industries.”
Source: Johnson Matthey
BASF will build a commercial scale battery recycling black mass plant in Schwarzheide, Germany. This investment strengthens BASF’s cathode active materials (CAM) production and recycling hub in Schwarzheide. The site is an ideal location for the build-up of battery recycling activities given the presence of many EV car manufacturers and cell producers in Central Europe.
Clariant says it is reducing its number of businesses from five to three, by merging units, under a reorganization that is in line with the company’s purpose-led strategy and cultural transformation. The moves will position Clariant for long-term sustainable growth, the company says.
Chemicals & plastics industry has the most diversified end-use market across all manufacturing industries. The industry returned to growth in 2021 but a supply chain crunch prevented it from becoming stronger. The market is likely to stabilize in the second half of 2022 with a supply-demand balance.